Rabinarayan Mishra

823 citations
10 papers · 336 indexed · h-index 9

Rabinarayan Mishra

10 papers receiving 330 citations

Peers

Rabinarayan Mishra
Comparison fields: 5 of 76
  • Immunology 177
  • Oncology 91
  • Infectious Diseases 49
  • Rehabilitation 13
  • Virology 8
Replace Frances E. Pearson with:
Frances E. Pearson Australia
Ann-Jay Tong United States
Oliver Schweier Germany
Gloria Esteso Spain
Maria Rosaria Bassi Denmark
Oscar Haigh France
Kim Wigglesworth United States
Michiko Shibano Japan
Coralie Guy Ireland
Sebastian Carrasco Pro United States
Rabinarayan Mishra relative to Frances E. Pearson Australia Frances E. Pearson's profile →
Citations per field
00.5×3.3×
Frances E. Pearson · 1×
Citations per year

Countries citing papers authored by Rabinarayan Mishra

Since Specialization
Citations

This map shows the geographic impact of Rabinarayan Mishra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rabinarayan Mishra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rabinarayan Mishra more than expected).

Fields of papers citing papers by Rabinarayan Mishra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rabinarayan Mishra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rabinarayan Mishra. The network helps show where Rabinarayan Mishra may publish in the future.

Co-authorship network

The 21 scholars most cited alongside Rabinarayan Mishra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rabinarayan Mishra Line = papers co-authored together Rabinarayan Mishra links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 201764
2 201732
3 201539
4 201422
5 20138
6 201313
7 201255
8 201154
9 201032
10 200917

About Rabinarayan Mishra

Rabinarayan Mishra is a scholar working on Immunology, Oncology, Health, Biotechnology and Animal Science and Zoology, having authored 10 papers that have together received 336 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (3 papers), Polyomavirus and related diseases (3 papers), Immunotherapy and Immune Responses (2 papers), Immune responses and vaccinations (2 papers), Virus-based gene therapy research (1 paper), Herpesvirus Infections and Treatments (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Immunology (177 citations), Oncology (91 citations), Infectious Diseases (49 citations), Rehabilitation (13 citations) and Virology (8 citations). Rabinarayan Mishra has collaborated with scholars based in United States and Croatia. Frequent co-authors include Eva Szomolanyi‐Tsuda, Raymond M. Welsh, Liisa K. Selin, Anna Gil, Dario Ghersi, Robert L. Garcea, Lawrence J. Stern, Nuray Aslan, Levi B. Watkin and Waldemar J. Racki. Their work appears in journals such as The Journal of Immunology, PLoS Pathogens, mBio, Transactions of the Royal Society of Tropical Medicine and Hygiene and Critical Reviews™ in Oncogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026